Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Empagliflozin 10 mg Tab
DRUG
2 trials
Sponsors
Saint Luke's Health System
, Mutah University
Conditions
Heart Failure
Pharmacokinetic Parameters
Phase 4
Empagliflozin Impact on Hemodynamics in Patients With Heart Failure
Completed
NCT03030222
Saint Luke's Health System
Heart Failure
Start: 2017-07-05
End: 2020-03-10
Updated: 2021-12-09
Unknown Phase
Pharmacokinetics and Bioequivalence of Two Empagliflozin, With Evaluation in Healthy Jordanian Subjects Under Fasting and Fed Conditions
Completed
NCT05229796
Mutah University
Pharmacokinetic Parameters
Start: 2021-05-17
End: 2021-12-12
Updated: 2022-02-08
Related Papers
Empagliflozin Effects on Pulmonary Artery Pressure in Patients With Heart Failure
Circulation
2021-02-08
260 citations
Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study.
2017-08-23
23 citations